tivators. In the RasN17 mutant, the affinity for GTP is 1999).
their yeast counterparts, but their regulation is poorly understood. Finally, there is the EFA-6 family of exchange factors that work preferentially on Arf6, the most distantly related member of the Arf family, and play an important role in early steps of endocytosis, and/or regulated exocytosis and actin cytoskeleton rearrangements at the plasma membrane (Franco et al., 1999). Mammalian cells of different origin have very different sensitivities to brefeldin A. For instance, in epithelial MDCK cells, the Golgi complex is surprisingly resistant to brefeldin A, but the AP-1/clathrin coat-dependent formation of vesicles on the trans-Golgi network, en route to the basolateral cell surface, is affected by brefeldin A (Orzech et al., 1999), suggesting that Arf exchange factors with different sensitivities to brefeldin A control the formation of these different organelles.
Interestingly, Arno, which has a Sec7 domain with a structure very similar to that of Gea2 (Goldberg, 1998), is much less sensitive to brefeldin A, indicating an exquisite specificity. Furthermore, the characterization of the mutations in brefeldin A-resistant mutants of Gea1 defines the site of brefeldin A action on the "Sec7 domain." cule is unlikely to bind to a target protein with the same 1998). However, the motifs flanking this Sec7 exchange affinity and specificity as its protein partner and is theredomain are different in each family, suggesting different fore unlikely to be an effective competitor. An inhibitor modes of regulation. The "small" exchange factors (47 that binds to a specific site on a protein complex in an kDa) of the Arno/Cytohesin/GRP1 family contain an uncompetitive manner might be more efficient. Also, it N-terminal coiled coil, a central Sec7 domain with a low seems that brefeldin A takes advantage of the resensitivity to brefeldin A, and a C-terminal PH domain arrangements that occur in the Arf-GDP:Sec7 domain that binds PIP3 (or PIP2). The PH domain is responsible complex while GDP is released. The concentration refor recruiting Arno to the membrane in response to sigquired for a drug to intercalate during this conformanals that increase PIP3 (or PIP2) levels, possibly in a tional rearrangement might be lower than the conlate stage of regulated secretion (Venkateswarlu et al., centration required to saturate a protein target with a 1998). Proteins in two other families of exchange factors competitive inhibitor. are much larger: bovine p200 is more closely related to Might this mechanism be useful for other targets of yeast Sec7 and is highly sensitive to brefeldin A (Moridrug discovery? Brefeldin A-sensitive Arf1 exchange naga et al., 1997), whereas GBF1 is more closely related factors themselves may not be useful targets: they play to yeast Gea1 and Gea2 (Mansour et al., 1998) and cona major role in constitutive secretion and brefeldin A is fers resistance to brefeldin A when overexpressed in therefore rather toxic for most cells. However, inhibitors mammalian cells (Yan et al., 1994) . GBF1 and p200 are of exchange factors for other small G proteins, such as Ras or Rac and Rho, might have therapeutic value. For thought to function in ER-through-Golgi transport, as
